Mycophenylate - a potential new option.
D015224:Dideoxynucleosides / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011355:Prodrugs / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000099227:Abacavir
D015224:Dideoxynucleosides; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D011355:Prodrugs; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir